Keyphrases
Active Treatment
20%
Acute Response
20%
Acute Treatment
20%
Antidepressants
100%
Continuation Therapy
20%
Continuation Treatment
40%
Depressed Patients
40%
Depression Treatment
20%
Illness
20%
Long-term Treatment
100%
Maintenance Studies
40%
Maintenance Therapy
20%
New Agents
20%
Patients at Risk
20%
Placebo
20%
Prospective Randomized Trial
20%
Randomized Design
20%
Recurrence Rate
20%
Remission
20%
Selective Serotonin Reuptake Inhibitors
100%
Tolerability
20%
Tricyclic Antidepressants
100%
INIS
antidepressants
100%
design
25%
doses
25%
lifetime
25%
maintenance
75%
patients
75%
recommendations
25%
reviews
100%
risks
25%
safety
25%
serotonin
100%
stabilization
25%
symptoms
25%
therapy
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Depression
100%
Diseases
66%
Placebo
33%
Recurrence Risk
33%
Recurrent Disease
33%
Relapse
33%
Remission
33%
Selective Serotonin Reuptake Inhibitor
100%
Tolerability
33%
Tricyclic Antidepressant
100%
Neuroscience
Antidepressant
100%
Depression
66%
Placebo
33%
Selective Serotonin Reuptake Inhibitor
100%
Treatment of Depression
33%
Tricyclic Antidepressant
100%